Literature DB >> 22786463

Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.

Nalini Sehgal1, Laxmaiah Manchikanti, Howard S Smith.   

Abstract

Both chronic pain and prescription opioid abuse are prevalent and continue to exact a heavy toll on patients, physicians, and society. Individuals with chronic pain and co-occurring substance use disorders and/or mental health disorders, are at a higher risk for misuse of prescribed opioids. Opioid abuse and misuse occurs for a variety of reasons, including self medication, use for reward, compulsive use because of addiction, and diversion for profit. Treatment approaches that balance treating chronic pain while minimizing risks for opioid abuse, misuse, and diversion are much needed. The use of chronic opioid therapy for chronic noncancer pain has increased dramatically in the past 2 decades in conjunction with a marked increase in the abuse of prescribed opioids and accidental opioid overdoses. Consequently, a validated screening instrument that provides an effective and rational method of selecting patients for opioid therapy, predicting risk, and identifying problems once they arise could be of enormous benefit. Such an instrument could potentially curb the risk of iatrogenic addiction. Although several screening instruments and strategies have been introduced in the past decade, there is no single test or instrument that can reliably and accurately predict patients who are not suitable for opioid therapy or identify those who need increased vigilance or monitoring during therapy. At present screening for opioid abuse includes assessment of premorbid and comorbid substance abuse; assessment of aberrant drug-related behaviors; risk factor stratification; and utilization of opioid screening tools. Multiple opioid assessment screening tools and instruments have been developed by various authors. In addition, urine drug testing, monitoring of prescribing practices, prescription monitoring programs, opioid treatment agreements, and utilization of universal precautions are essential. Presently, a combination of strategies is recommended to stratify risk, identify and understand aberrant drug related behaviors, and tailor treatments accordingly. This manuscript will review the current state of knowledge regarding the growing problem of opioid abuse and misuse; known risk factors; and methods of predicting, assessing, monitoring, and addressing opioid abuse and misuse in patients with chronic noncancer pain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22786463

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  82 in total

1.  Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.

Authors:  William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2018-11-26       Impact factor: 4.492

Review 2.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

3.  Negative Affect-Related Factors Have the Strongest Association with Prescription Opioid Misuse in a Cross-Sectional Cohort of Patients with Chronic Pain.

Authors:  Gadi Gilam; John A Sturgeon; Dokyoung S You; Ajay D Wasan; Beth D Darnall; Sean C Mackey
Journal:  Pain Med       Date:  2020-02-01       Impact factor: 3.750

4.  Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study for Customized Computer-Based Testing.

Authors:  Matthew D Finkelman; Ronald J Kulich; Kevin L Zacharoff; Niels Smits; Britta E Magnuson; Jinghui Dong; Stephen F Butler
Journal:  Pain Med       Date:  2015-07-14       Impact factor: 3.750

5.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

6.  Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Authors:  Merav Kovatch; Daniel Feingold; Odelia Elkana; Shaul Lev-Ran
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-23       Impact factor: 4.035

7.  A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.

Authors:  Alan K Davis; Elise Renn; Austin-Marley Windham-Herman; Martin Polanco; Joseph P Barsuglia
Journal:  J Psychoactive Drugs       Date:  2018-07-18

Review 8.  The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.

Authors:  Ann P Lin; Mei-Chuan Ko
Journal:  ACS Chem Neurosci       Date:  2012-11-06       Impact factor: 4.418

Review 9.  Managing Chronic Pain in Special Populations with Emphasis on Pediatric, Geriatric, and Drug Abuser Populations.

Authors:  Kyle M Baumbauer; Erin E Young; Angela R Starkweather; Jessica W Guite; Beth S Russell; Renee C B Manworren
Journal:  Med Clin North Am       Date:  2016-01       Impact factor: 5.456

10.  Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain.

Authors:  M O Martel; A D Wasan; R N Jamison; R R Edwards
Journal:  Drug Alcohol Depend       Date:  2013-04-22       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.